Phathom Pharmaceuticals, Inc. (PHAT)
12.67
+0.04
(+0.32%)
USD |
NASDAQ |
Apr 13, 16:00
12.67
0.00 (0.00%)
After-Hours: 18:20
Phathom Pharmaceuticals Cash from Investing (TTM) : -0.229M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Replimune Group, Inc. | 216.64M |
| ANI Pharmaceuticals, Inc. | -34.32M |
| MannKind Corp. | -304.80M |
| Ocugen, Inc. | -0.311M |
| Ligand Pharmaceuticals, Inc. | -377.32M |